MedPath

The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients.

Not Applicable
Completed
Conditions
HD Patients
Registration Number
JPRN-jRCT1090220207
Lead Sponsor
Shigeru Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

HD Patients

Exclusion Criteria

100<Serum Ferritin

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum concentration of Ca,P,Iron regulatory factors.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath